Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1983-07-26
1985-01-01
Hazel, Blondel
Chemistry: molecular biology and microbiology
Spore forming or isolating process
424 85, 424 86, 935103, 4351722, C12N 500, C12N 1500
Patent
active
044916329
ABSTRACT:
Cell lines for producing monoclonal antibodies to hepatitis virus are established by immunizing animal lymphocytes with hepatitis antigen to form antibody producing cells which then are fused with myeloma cells. The resultant somatic cell hybrids can be cloned. These clones produce monoclonal antibodies to individual antigenic determinates unique to hepatitis virus.
REFERENCES:
patent: 4196265 (1980-04-01), Koprowski et al.
Diamandopoulous, B. T., Journal of the National Cancer Institute, vol. 50, p. 1347, (1978).
Raschke, V. V. C., Curr. Top. Microbiol. Immunol., vol. 81, p. 70, (1978).
Galfre et al., Nature, vol. 277, pp. 131-133, 1979.
The Lancet, Editorial, pp. 1242-1243, Jun. 11, 1977.
Wands Jack R.
Zurawski, Jr. Vincent R.
Hazel Blondel
The Massachusetts General Hospital
LandOfFree
Process for producing antibodies to hepatitis virus and cell lin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for producing antibodies to hepatitis virus and cell lin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for producing antibodies to hepatitis virus and cell lin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-577557